why choose us

First received: August 31, 2023

Clinical Trial: Study of RMC-9805 in Participants With KRASG12D-Mutant Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-small Cell Lung Cancer (NSCLC)

Study Type: INTERVENTIONAL


Official Title: Phase 1/1b, Multicenter, Open-Label, Study of RMC 9805 in Participants With Advanced KRASG12D-Mutant Solid Tumors

Brief Summary: This study is to evaluate the safety and tolerability of RMC-9805 in adults with KRAS G12D-mutant solid tumors.

Read more